Page last updated: 2024-09-04

dx 8951 and dalteparin

dx 8951 has been researched along with dalteparin in 1 studies

Compound Research Comparison

Studies (dx 8951)	Trials (dx 8951)	Recent Studies (post-2010) (dx 8951)	Studies (dalteparin)	Trials (dalteparin)	Recent Studies (post-2010) (dalteparin)
73	18	15	5,665	1,423	2,267

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alexander, J; Becker, RC; Bovill, E; Dyke, CK; Harrington, RA; Kunitada, S; Li, YF; Robertson, TL; Spencer, FA	1

Other Studies

1 other study(ies) available for dx 8951 and dalteparin

Article	Year
Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist. Thrombosis and haemostasis, 2004, Volume: 92, Issue:6 Topics: Anticoagulants; Blood Coagulation Tests; Calcium Chloride; Camptothecin; Drug Synergism; Enoxaparin; Factor Xa; Factor Xa Inhibitors; Heparin; Heparin, Low-Molecular-Weight; Humans; Sensitivity and Specificity	2004

Article

Year

Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist.

Thrombosis and haemostasis, 2004, Volume: 92, Issue:6

Topics: Anticoagulants; Blood Coagulation Tests; Calcium Chloride; Camptothecin; Drug Synergism; Enoxaparin; Factor Xa; Factor Xa Inhibitors; Heparin; Heparin, Low-Molecular-Weight; Humans; Sensitivity and Specificity

2004